Ovarian cancer immune cell study aims to unlock treatment clues
NCT ID NCT03922776
First seen Mar 23, 2026 · Last updated May 14, 2026 · Updated 12 times
Summary
This study collected blood, fluid, and tissue samples from 36 women with advanced ovarian or fallopian tube cancer to analyze immune cells before and after chemotherapy. The goal was to understand how the immune system responds to the cancer and treatment. The study was terminated early, so results may be limited.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVARIAN CANCER STAGE IV are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centre Oscar Lambret
Lille, France, 59020, France
Conditions
Explore the condition pages connected to this study.